Healthcare -
Biotechnology - NASDAQ - US
$ 8.09
-1.17 %
$ 838 M
Market Cap
-1.45
P/E
NTLA - NET INCOME
Net Income NTLA - Intellia Therapeutics, Inc.
-519 M
LAST VALUE
-4.62%
2 YEAR CAGR
-39.14%
5 YEAR CAGR
-43.21%
10 YEAR CAGR